Food & Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food & Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Children's Hospital of Philadelphia
Steroids may contribute to increased bone mass in nephritic syndrome patients
September 24th, 2004
According to a new study, children who take steroid drugs for nephrotic syndrome do not suffer bone loss, a common side effect of steroid treatments in adults, as the drug frequently causes obesity, which seems to protect children against bone loss. Childhood nephrotic syndrome, the most common chronic kidney disease in children, does not impair kidney function, but weakens the body's ability to remove water and salt from the blood, and causes swelling in the belly, legs, and around the eyes. Left untreated, the syndrome may progress to life-threatening complications. Fortunately, most cases of childhood nephrotic syndrome are steroid-sensitive,...
Source: Food & Drug Law Weekly (2004-09-24)
|
